HealthNewsAPI
Ozempic may be reshaping the brain, scientists say - Ground News
Overview
Scientists are investigating how GLP-1 drugs such as semaglutide may change brain circuits involved in reward, mood and behavior, which could explain reports of emotional blunting. The new study suggesting a lower breast cancer risk underscores that these medications can have systemic effects beyond the brain and metabolism, highlighting the need to study multi-organ outcomes when assessing benefits and harms. Clinicians should monitor both neurological and broader physical health changes as more evidence accumulates.
Entities
ORGRealClearPoliticsORGGround NewsORGUniversity of Colorado AnschutzLOCColoradoJill B
Relationship Graph
Click a connection line between nodes to view confidence and evidence.
Nodes: 5 · Connections: 4
Caused by
Led to
Related to
Same event
Press enter or space to select a node. You can then use the arrow keys to move the node around. Press delete to remove it and escape to cancel.
Press enter or space to select an edge. You can then press delete to remove it or escape to cancel.
Click a connection for evidence · click a node to open it
Select a connection to see why these events are linked.